Gene, Cell, + RNA Therapy Landscape Q3 2023 Report
Report
商業化支援サービス
Q3 2023 saw 3,866 therapies in development; 53% of those were gene therapies, 25% RNA therapies, and 22% non-genetically modified cell therapies.